Bloomberg: AstraZeneca Wants To Hold Another Vaccine Trial

Bloomberg: AstraZeneca Wants To Hold Another Vaccine Trial

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

AstraZeneca's vaccine trial initially reported 62% effectiveness with a full two-dose regimen and 90% with a dose and a half. However, the latter was due to a mistake in dosage concentration. The CEO plans to intentionally test the one and a half dosage to verify the 90% efficacy.

Read more

2 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What did some of the vials used in the trial contain?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What does the AstraZeneca CEO want to do with the one and a half dosage?

Evaluate responses using AI:

OFF